A citation-based method for searching scientific literature




Volker Vallon, Maria Gerasimova, Michael A Rose, Takahiro Masuda, Joseph Satriano, Eric Mayoux, Hermann Koepsell, Scott C Thomson, Timo Rieg. Am J Physiol Renal Physiol 2014
Times Cited: 252




List of shared articles



Times cited

Organ protection by SGLT2 inhibitors: role of metabolic energy and water conservation.
Adriana Marton, Tatsuroh Kaneko, Jean-Paul Kovalik, Atsutaka Yasui, Akira Nishiyama, Kento Kitada, Jens Titze. Nat Rev Nephrol 2021
17

SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
Katherine R Tuttle, Frank C Brosius, Matthew A Cavender, Paola Fioretto, Kevin J Fowler, Hiddo J L Heerspink, Tom Manley, Darren K McGuire, Mark E Molitch, Amy K Mottl,[...]. Diabetes 2021
3

SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
Katherine R Tuttle, Frank C Brosius, Matthew A Cavender, Paola Fioretto, Kevin J Fowler, Hiddo J L Heerspink, Tom Manley, Darren K McGuire, Mark E Molitch, Amy K Mottl,[...]. Am J Kidney Dis 2021
11

Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function.
Volker Vallon, Subodh Verma. Annu Rev Physiol 2021
12

Renal effects of SGLT2 inhibitors: an update.
Josselin Nespoux, Volker Vallon. Curr Opin Nephrol Hypertens 2020
13

Osmotic diuresis by SGLT2 inhibition stimulates vasopressin-induced water reabsorption to maintain body fluid volume.
Takahiro Masuda, Shigeaki Muto, Keiko Fukuda, Minami Watanabe, Ken Ohara, Hermann Koepsell, Volker Vallon, Daisuke Nagata. Physiol Rep 2020
19

Inflammatory Targets in Diabetic Nephropathy.
Javier Donate-Correa, Desirée Luis-Rodríguez, Ernesto Martín-Núñez, Víctor G Tagua, Carolina Hernández-Carballo, Carla Ferri, Ana Elena Rodríguez-Rodríguez, Carmen Mora-Fernández, Juan F Navarro-González. J Clin Med 2020
30

Gene knockout of the Na+-glucose cotransporter SGLT2 in a murine model of acute kidney injury induced by ischemia-reperfusion.
Josselin Nespoux, Rohit Patel, Haiyan Zhang, Winnie Huang, Brent Freeman, Paul W Sanders, Young Chul Kim, Volker Vallon. Am J Physiol Renal Physiol 2020
7


The tubular hypothesis of nephron filtration and diabetic kidney disease.
Volker Vallon, Scott C Thomson. Nat Rev Nephrol 2020
49

Empagliflozin Protects Against Proximal Renal Tubular Cell Injury Induced by High Glucose via Regulation of Hypoxia-Inducible Factor 1-Alpha.
Angelamellisy Revelian Ndibalema, Deo Kabuye, Si Wen, Lulu Li, Xin Li, Qiuling Fan. Diabetes Metab Syndr Obes 2020
6

Consistent effects of empagliflozin on cardiovascular and kidney outcomes irrespective of diabetic kidney disease categories: Insights from the EMPA-REG OUTCOME trial.
Christoph Wanner, Silvio E Inzucchi, Bernard Zinman, Audrey Koitka-Weber, Michaela Mattheus, Jyothis T George, Maximilian von Eynatten, Sibylle J Hauske. Diabetes Obes Metab 2020
5

A role for tubular Na+/H+ exchanger NHE3 in the natriuretic effect of the SGLT2 inhibitor empagliflozin.
Akira Onishi, Yiling Fu, Rohit Patel, Manjula Darshi, Maria Crespo-Masip, Winnie Huang, Panai Song, Brent Freeman, Young Chul Kim, Manoocher Soleimani,[...]. Am J Physiol Renal Physiol 2020
20